Mónica Toribio

No ORCID on file · 5 papers in corpus · active 2009-2024

Study types

  • article 4
  • other 1

Condition tags

  • endometriosis 3
  • endometrioma 1
other 2024
Identification of miR-30c-5p microRNA in Serum as a Candidate Biomarker to Diagnose Endometriosis
International journal of molecular sciences ·doi:10.3390/ijms25031853

The diagnosis of endometriosis by laparoscopy is delayed until advanced stages. In recent years, microRNAs have emerged as novel biomarkers for different diseases. These molecules are small non-coding RNA sequences involved in the regulatio…

article 2023
A Randomized Controlled Intervention Trial with Danazol to Improve Telomeric and Fertility Parameters in Women with Diminished Ovarian Reserve: A Pilot Study
·doi:10.1089/whr.2023.0013

Background: fertilization (IVF) clinics have trouble conceiving due to ovarian failure (OF), which seems to be associated to short telomeres and reduced or absent telomerase activity in their granulosa cells. Indeed, telomere pathways are i…

article 2022
P-629 A prospective, randomized, placebo-controlled pilot trial investigating telomere length dynamics and ovarian function in patients with diminished ovarian reserve (DOR) after danazol treatment
·doi:10.1093/humrep/deac107.578

Abstract Study question Could the administration of a synthetic steroid -danazol- for 3 months reactivate telomerase activity and lengthen telomeres in patients with DOR? Summary answer Danazol treatment resulted in an increase of the mean …

article 2009
Decreased concentrations of AMH in follicular fluid of women with endometriosis: A hypothetical newmarker of oocyte quality
·doi:10.5301/je.2009.4649

IntroductionAnti-mullerian hormone (AMH) has been recently introduced as a new marker of ovarian reserve with a high sensitivity and with the added value of being independent of cycle day. Some aut...

article 2009
Decreased Concentrations of AMH in Follicular Fluid of Women with Endometriosis: A Hypothetical New Marker of Oocyte Quality
·doi:10.1177/228402650900100108

Introduction Anti-müllerian hormone (AMH) has been recently introduced as a new marker of ovarian reserve with a high sensitivity and with the added value of being independent of cycle day. Some authors have claimed that it may also provide…